Orthopediatrics (KIDS) Non-Current Deffered Revenue (2019)
Orthopediatrics (KIDS) recorded quarterly Non-Current Deffered Revenue of $12.4 million in Q4 2019.
Orthopediatrics (KIDS) Non-Current Deffered Revenue (2019) Analysis & Trends
Orthopediatrics' Non-Current Deffered Revenue history runs 1 years deep, the most recent figure standing at $12.4 million for Q4 2019.
- In Q4 2019, Non-Current Deffered Revenue changed N/A year-over-year to $12.4 million; the TTM figure through Dec 2019 stood at $12.4 million (changed N/A YoY), while the FY2019 annual figure was $12.4 million, changed N/A from the prior year.
- Non-Current Deffered Revenue was $12.4 million for Q4 2019 at Orthopediatrics.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $12.4 million in Q4 2019 to a low of $12.4 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Orthopediatrics | 424.91 Mn | 376.10 Mn | 43.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 12.41 Mn |